Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Emerging biomarkers in Gaucher disease
Danielle M. Luettel
,
Marcia R. Terluk
, Jaehyeok Roh
, Neal J. Weinreb
,
Reena V. Kartha
Experimental and Clinical Pharmacology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
7
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Emerging biomarkers in Gaucher disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gaucher Disease
100%
Emerging Biomarkers
100%
Inflammation
14%
Novel Therapeutic Targets
14%
Disease Management
14%
Disease Diagnosis
14%
Neuropathy
14%
Quality of Life
14%
Lysosomal Disease
14%
Potential Identification
14%
Anemia
14%
Macrophages
14%
Potential Biomarkers
14%
Glycosphingolipids
14%
Thrombocytopenia
14%
Disease Treatment
14%
Neuronopathy
14%
Disease Status
14%
Bone Pain
14%
Change Assessment
14%
Distinct Subtypes
14%
Hepatosplenomegaly
14%
Disease Potential
14%
Enzyme Deficiency
14%
Abnormal Eye Movements
14%
Easy Bruising
14%
Skeletal Pathology
14%
Glucocerebrosidase Deficiency
14%
Toxic Substrates
14%
Disease Monitoring
14%
Mild Form
14%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Gaucher's Disease
100%
Diseases
50%
Gaucher Disease Type 1
16%
Glucosylceramidase
16%
Neuropathy
16%
Bone Pain
16%
Hepatosplenomegaly
16%
Glycosphingolipid
16%
Eye Movement Disorder
16%
Inflammation
16%
Anemia
16%
Enzymes
16%
Thrombocytopenia
16%
Biochemistry, Genetics and Molecular Biology
Gaucher's Disease
100%
Macrophage
14%
Glucocerebrosidase
14%
GD2
14%
Enzyme
14%
Eye Movement
14%
Thrombocytopenia
14%
Glucosylceramidase
14%
Glycosphingolipid
14%
Deficiency
14%
Agricultural and Biological Sciences
Glucosylceramidase
14%
Glucocerebrosidase
14%